Saliba Richard S, Munro Peter M G, Luthert Philip J, Cheetham Michael E
Division of Pathology, Institute of Ophthalmology, University College London, UK.
J Cell Sci. 2002 Jul 15;115(Pt 14):2907-18. doi: 10.1242/jcs.115.14.2907.
Mutations in the photopigment rhodopsin are the major cause of autosomal dominant retinitis pigmentosa. The majority of mutations in rhodopsin lead to misfolding of the protein. Through the detailed examination of P23H and K296E mutant opsin processing in COS-7 cells, we have shown that the mutant protein does not accumulate in the Golgi, as previously thought, instead it forms aggregates that have many of the characteristic features of an aggresome. The aggregates form close to the centrosome and lead to the dispersal of the Golgi apparatus. Furthermore, these aggregates are ubiquitinated, recruit cellular chaperones and disrupt the intermediate filament network. Mutant opsin expression can disrupt the processing of normal opsin, as co-transfection revealed that the wild-type protein is recruited to mutant opsin aggregates. The degradation of mutant opsin is dependent on the proteasome machinery. Unlike the situation with DeltaF508-CFTR, proteasome inhibition does not lead to a marked increase in aggresome formation but increases the retention of the protein within the ER, suggesting that the proteasome is required for the efficient retrotranslocation of the mutant protein. Inhibition of N-linked glycosylation with tunicamycin leads to the selective retention of the mutant protein within the ER and increases the steady state level of mutant opsin. Glycosylation, however, has no influence on the biogenesis and targeting of wild-type opsin in cultured cells. This demonstrates that N-linked glycosylation is required for ER-associated degradation of the mutant protein but is not essential for the quality control of opsin folding. The addition of 9-cis-retinal to the media increased the amount of P23H, but not K296E, that was soluble and reached the plasma membrane. These data show that rhodopsin autosomal dominant retinitis pigmentosa is similar to many other neurodegenerative diseases in which the formation of intracellular protein aggregates is central to disease pathogenesis, and they suggest a mechanism for disease dominance.
光色素视紫红质的突变是常染色体显性视网膜色素变性的主要病因。视紫红质中的大多数突变会导致蛋白质错误折叠。通过对COS-7细胞中P23H和K296E突变视蛋白加工过程的详细研究,我们发现突变蛋白并不像之前认为的那样在高尔基体中积累,而是形成具有许多聚集体特征的聚集体。这些聚集体在靠近中心体的位置形成,并导致高尔基体的分散。此外,这些聚集体被泛素化,招募细胞伴侣并破坏中间丝网络。突变视蛋白的表达会干扰正常视蛋白的加工,因为共转染显示野生型蛋白会被招募到突变视蛋白聚集体中。突变视蛋白的降解依赖于蛋白酶体机制。与DeltaF508-CFTR的情况不同,蛋白酶体抑制并不会导致聚集体形成显著增加,但会增加蛋白质在内质网中的滞留,这表明蛋白酶体是突变蛋白有效逆向转运所必需的。用衣霉素抑制N-连接糖基化会导致突变蛋白在内质网中的选择性滞留,并增加突变视蛋白的稳态水平。然而,糖基化对培养细胞中野生型视蛋白的生物合成和靶向没有影响。这表明N-连接糖基化是突变蛋白内质网相关降解所必需的,但对视蛋白折叠的质量控制并非必不可少。向培养基中添加9-顺式视黄醛会增加可溶并到达质膜的P23H的量,但不会增加K296E的量。这些数据表明,视紫红质常染色体显性视网膜色素变性与许多其他神经退行性疾病相似,在这些疾病中,细胞内蛋白质聚集体的形成是疾病发病机制的核心,并且它们提出了一种疾病显性的机制。